Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Study Finds Rules for Cancer Drivers

Published: Monday, September 30, 2013
Last Updated: Monday, September 30, 2013
Bookmark and Share
Any number of alterations to an individual’s genetic code has the potential to make a cell malfunction and proliferate into cancer tumors.

Identifying the genetic changes that lead to cancer – and the rules that govern those changes – has been a key goal in the field of cancer genomics. It is a task made more challenging by the diversity of cancer types and the seemingly distinct biology of different types of cancers.

This week, researchers from the Genome Characterization Center (GCC) at the Broad Institute announced that they had identified some rules that apply across cancers for a specific type of genetic mutation – somatic copy number alterations (SCNAs). SCNAs are deletions or duplications of certain regions of the genome, and are some of the most common mutations that occur in cancer.

In the largest such study to date, the team looked at nearly 5,000 cancer samples from across 12 cancer types – including breast, bladder, and colon cancer, among others – for patterns in the occurrence of SCNAs. Their study, which appears in Nature Genetics, identified common ways in which these copy number changes are generated in cancer, and located specific genes and regions involved.

“Our goal was to find patterns that are universal across cancer,” said Matthew Meyerson, a senior associate member at the Broad and one of the study’s co-senior authors. “Finding these patterns across cancer types suggests that different cancers tend to result from similar or even the same underlying events, and therefore arise from many of the same pathways.”

The findings also serve as a database that researchers can draw from in future investigations.

“This paper gives researchers a large compendium of new genes and processes to look at that may play an essential role in individual cancers, enabling the research community to identify new causes and molecular pathways that may one day be targeted to treat cancer,” said Rameen Beroukhim, the lead investigator of the study and a co-senior author of the paper. Beroukhim is an associate member of the Broad, and an assistant professor at Dana-Farber Cancer Institute and Harvard Medical School.

The team found that, across cancer types, somatic copy number alterations adhered to the following rules:

Whole-genome doubling is associated with higher rates of every other type of copy number alteration. Whole-genome doubling is one of the major sources of copy number changes in tumors, occurring in about 37% of cancers. As the term suggests, it happens when the entire genome of an organism duplicates, so instead of producing the usual two of each chromosome, a person will produce four. The GCC study found that, in cancer, whole-genome doubling tends to trigger additional copy number alterations. The team found that the genes TP53 and CCNE1 – which had previously been linked to whole-genome doubling – were associated with these cancer-related events. They also found two new genes whose mutations contribute to the doubling of cancer genomes: PPP2R2A and PPP2R1A.

SCNAs that occur within chromosomes and those that occur at the ends of chromosomes are most likely caused by different mechanisms. The team found that copy number alterations that begin at the protective ends of chromosomes (called “telomeres”) tend to be longer than alterations that occur within chromosomes. The significant difference between these two types of SCNAs suggests that two distinct mechanisms are at work: one that causes copy number alterations that extend at the telomere, and a different one that can create internal, chromosomal copy number changes.

There are 140 regions of the genome that seem to be affected by somatic copy number alterations. Across all 12 cancer types examined in the study, these 140 regions were consistently altered. Of these regions, only 35 contained genes that were previously linked to cancer. The remaining regions house a large number of new candidate genes that may prove to be cancer drivers.

SCNAs can affect the epigenetic regulators that control how genes are expressed, contributing to cancer. Many of the 140 regions identified by the study are known to contain epigenetic regulators. These regulators modify how DNA is folded within the cell and what parts of the DNA’s genetic code can be read, which in turn affects how genes are expressed. This evidence suggests that some cancer patient populations may benefit from treatments that target these epigenetic regulators.

The GCC study was conducted as part The Cancer Genome Atlas (TCGA) Project, a national, multi-institution collaboration to characterize the genomes of over 20 types of cancer and to uncover the molecular basis of the disease. The Broad GCC site is one of six TCGA Genome Characterization Centers. Meyerson, who is one of the Broad GCC’s principal investigators, said the goal of the center is to provide copy number analysis of all of the tumors that are analyzed by TCGA.

“This paper is really the first report of that copy number analysis, systematically across cancer,” explained Meyerson, who is also an associate professor of pathology and medical oncology at Dana-Farber Cancer Institute. “It is the culmination of years of work in this area at the Broad, and the product of a data generation and analytical pipeline that is built upon a very long tradition of Broad research.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GTEx: Useful Expression For Cancer Research
GTEx Project has recently published several papers reporting on findings from its two-year pilot phase.
Tuesday, May 26, 2015
In vivo CRISPR-Cas9 Screen Sheds Light On Cancer Metastasis And Tumor Evolution
Genome-scale study points to drivers of tumor evolution and metastasis, provides roadmap for future in vivo Cas9 screens.
Friday, March 06, 2015
Disorder in Gene-Control System is a Defining Characteristic of Cancer, Study Finds
Findings indicate that the disarray in the on-off mechanism is one of the defining characteristics of cancer.
Tuesday, December 23, 2014
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
Thursday, November 27, 2014
Dramatic Response And Resistance To Cancer Drug Traced
Sequencing reveals why thyroid tumor responded to, and eventually resisted, treatment.
Friday, October 10, 2014
Study Expands the Cancer Genomics Universe
The universe of cancer mutations is much bigger than previously thought, and key cancer genes are still to be discovered.
Tuesday, January 28, 2014
Predicting Cancer’s Next Move
Research offers a new approach to studying drug resistance in cancer.
Monday, November 11, 2013
Broad Institute and Bayer Join Forces
The Broad Institute has entered into a strategic alliance with Bayer Healthcare in the area of oncogenomics and drug discovery.
Wednesday, September 11, 2013
Bringing Out the Usual – and Unusual – Cancer Genomics Suspects
Several years ago, researchers sequencing lung cancer genomes encountered a number of red herrings.
Tuesday, June 18, 2013
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Monday, June 10, 2013
ATARiS Informatics Platform Hits the Jackpot
ATARiS is one of several tools developed at the Broad Institute to precisely tune in to the signals within noisy datasets.
Wednesday, May 22, 2013
Researchers Unearth New Clues About How Prostate Cancer Evolved
With the help of a computational model, Broad researchers were able to reconstruct the genomes of prostate cancer cells.
Thursday, May 16, 2013
Endometrial Cancer Findings Emerge from Genome Sequencing Study
Novel tumor sub-types have been identified that could lead to better risk stratification and more individualized and targeted treatments.
Friday, May 10, 2013
Delivering on a Promise: Nanoparticles Carry siRNA to Tumours
RNA interference, a gene-silencing phenomenon discovered in the late 1990s, was hailed for its potential as a treatment in cancer and other diseases.
Friday, September 21, 2012
New Potential Targets Discovered for Treating Squamous Cell Lung Cancers
The Cancer Genome Atlas finds important genomic alterations in second most common lung cancer type.
Monday, September 10, 2012
Scientific News
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos